Skip to content

LivaNova LIVN Current ratio

Current ratio at other companies

Abbott logo
AbbottABT
1.4×-0.4×
Haemonetics logo
HaemoneticsHAE
+1.3×
Medtronic logo
MedtronicMDT
2.1×+0.3×
ResMed logo
ResMedRMD
-0.4×
Boston Scientific logo
Boston ScientificBSX
1.9×+0.4×
Stryker logo
StrykerSYK
2.1×+0.5×

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×

Where this comes from

Calculated from LivaNova’s reported figures.

Based on the most recent quarter.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's current ratio?
LivaNova (LIVN) reported current ratio of 1.3× in Q1 2026.
How has LivaNova's current ratio changed year-over-year?
LivaNova's current ratio decreased by 15.8% year-over-year, from 1.6× to 1.3×.
What is the long-term trend for LivaNova's current ratio?
Over 5 years (2020 to 2025), LivaNova's current ratio has grown at a -9.9% compound annual growth rate (CAGR), from 2.3× to 1.4×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.